US Patent Issued to Boston Scientific on May 13 for "Bodily substance detection by evaluating photoluminescent response to excitation radiation" (German Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,295,655, issued on May 13, was assigned to Boston Scientific Corp. (Marlborough, Mass.).

"Bodily substance detection by evaluating photoluminescent response to excitation radiation" was invented by Ralf Brinkmann (Grevenbroich, Germany) and Birgit Lange (Lubeck, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "A medical device may include an ablation device configured to deliver ablation energy to a treatment site. The medical device may further include a probe device configured to deliver excitation radiation to the treatment site. Further the medical device may include a radiation-receiving device configured to receive photoluminescence radiatio...